Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells.
Open Access
- 1 August 1991
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 88 (2) , 379-384
- https://doi.org/10.1172/jci115314
Abstract
Previous reports have suggested the production of complement components C4, C2, and factor B by renal tissue. However, the cells involved in production of complement have not been identified. In this study metabolic labeling experiments demonstrated that human proximal tubular epithelial cells (PTEC) synthesize a 180-kD precursor of C3 that is secreted after proteolytic cleavage into a disulphide linked two-chain molecule as found in plasma. C3 present in culture supernatants of PTEC was functionally active, however, during the culture period there was a partial inactivation of the C3 molecule as assessed by hemolytic titration. Recombinant IL-2 enhances the rate of C3 synthesis in a dose-dependent manner reaching maximal stimulation at doses of 200-400 U/ml IL-2. Northern blot analysis demonstrated a 5.2-kb C3 mRNA species present in PTEC that was increased within 24 h of IL-2 treatment. IL-2-induced enhancement of C3 production by PTEC could be neutralized with specific antibodies to IL-2. This study demonstrates that C3 synthesis in PTEC is upregulated by IL-2, the major cytokine produced by activated T cells.Keywords
This publication has 33 references indexed in Scilit:
- Expression and role of p75 interleukin 2 receptor on human monocytes.The Journal of Experimental Medicine, 1990
- Classical pathway of complement activation in normal and diseased human glomeruliKidney International, 1989
- DONOR-SPECIFIC LYSIS OF HUMAN KIDNEY PROXIMAL TUBULAR EPITHELIAL CELLS BY RENAL ALLOGRAFT-INFILTRATING LYMPHOCYTESTransplantation, 1989
- THE 3RD COMPONENT OF COMPLEMENT IS TRANSCRIBED AND SECRETED BY CULTURED HUMAN-ENDOTHELIAL CELLS1987
- Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease.Journal of Clinical Oncology, 1986
- Immunohistochemical study of the C5b-9 complex of complement in human kidneysKidney International, 1986
- Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.The Journal of Immunology, 1985
- Biosynthesis of complement by human monocytesClinical Immunology and Immunopathology, 1981
- Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with α 2-macroglobulinBiochemical Journal, 1981
- Human C′3: Evidence for the Liver as the Primary Site of SynthesisScience, 1969